BGIM
GSK icon

Brandywine Global Investment Management’s GSK GSK Stock Holding History

Brandywine Global Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$54.7M Sell
1,116,087
-27,462
-2% -$1.28M 0.37% 80
2025
Q3 		$49.4M Sell
1,143,549
-366,835
-24% -$14.3M 0.34% 87
2025
Q2 		$58M Sell
1,510,384
-224
-0% -$8.56K 0.41% 62
2025
Q1 		$58.5M Sell
1,510,608
-87,389
-5% -$3.2M 0.42% 58
2024
Q4 		$54M Sell
1,597,997
-6,499
-0.4% -$234K 0.39% 67
2024
Q3 		$62.8M Buy
1,604,496
+4,645
+0.3% +$190K 0.42% 64
2024
Q2 		$61.6M Sell
1,599,851
-62,163
-4% -$2.61M 0.46% 52
2024
Q1 		$71.3M Buy
1,662,014
+95,903
+6% +$3.95M 0.51% 50
2023
Q4 		$58M Buy
1,566,111
+122,534
+8% +$4.4M 0.47% 56
2023
Q3 		$52.3M Sell
1,443,577
-53,115
-4% -$1.89M 0.46% 60
2023
Q2 		$53.3M Buy
1,496,692
+133,323
+10% +$4.78M 0.44% 64
2023
Q1 		$48.5M Sell
1,363,369
-56,501
-4% -$1.98M 0.39% 72
2022
Q4 		$49.9M Buy
1,419,870
+161,017
+13% +$5.36M 0.39% 74
2022
Q3 		$37M Buy
1,258,853
+211,201
+20% +$8M 0.35% 84
2022
Q2 		$57M Sell
1,047,652
-24,931
-2% -$1.38M 0.5% 54
2022
Q1 		$58.4M Sell
1,072,583
-30,975
-3% -$1.68M 0.43% 67
2021
Q4 		$60.8M Buy
1,103,558
+159,437
+17% +$8.29M 0.43% 59
2021
Q3 		$45.1M Buy
944,121
+142,691
+18% +$7.17M 0.34% 79
2021
Q2 		$39.9M Buy
801,430
+159,601
+25% +$7.67M 0.3% 78
2021
Q1 		$28.6M Buy
641,829
+43,812
+7% +$1.99M 0.22% 126
2020
Q4 		$27.5M Buy
+598,017
New +$27.5M 0.23% 117
2014
Q1 		– Sell
-1,017,497
Closed -$67.9M – 956
2013
Q4 		$67.9M Sell
1,017,497
-10,093
-1% -$654K 0.62% 40
2013
Q3 		$64.4M Sell
1,027,590
-16,283
-2% -$1.05M 0.64% 36
2013
Q2 		$65.2M Buy
+1,043,873
New +$66.3M 0.67% 32

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Brandywine Global Investment Management's GSK Position: Q4 2025 in Review

Brandywine Global Investment Management reduced its GSK (GSK) stake by 2.4% in Q4 2025, selling an estimated $1.28M and leaving 1,116,087 shares worth $54.7M. The position accounts for 0.37% of the portfolio, ranked #80.

Brandywine Global Investment Management first reported a position in GSK in Q2 2013 and has held it in 24 quarters since. The position peaked at $71.3M in Q1 2024. 995 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

  • Brandywine Global Investment Management held 1,116,087 shares of GSK worth $54.7M as of Q4 2025.
  • Brandywine Global Investment Management sold 27,462 GSK shares in Q4 2025, an estimated $1.28M.
  • GSK made up 0.37% of Brandywine Global Investment Management's portfolio in Q4 2025, its #80 holding.
  • Brandywine Global Investment Management first reported a position in GSK in Q2 2013 and has held it in 24 quarters since.
  • Brandywine Global Investment Management's GSK position peaked at $71.3M in Q1 2024.
  • 995 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on Brandywine Global Investment Management's 13F filing for Q4 2025, filed 11 Feb 2026.